UA93390C2 - Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation - Google Patents
Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparationInfo
- Publication number
- UA93390C2 UA93390C2 UAA200805952A UAA200805952A UA93390C2 UA 93390 C2 UA93390 C2 UA 93390C2 UA A200805952 A UAA200805952 A UA A200805952A UA A200805952 A UAA200805952 A UA A200805952A UA 93390 C2 UA93390 C2 UA 93390C2
- Authority
- UA
- Ukraine
- Prior art keywords
- cannabinoid receptor
- preparation
- pharmaceutical compositions
- compositions containing
- receptor ligands
- Prior art date
Links
- 102000018208 Cannabinoid Receptor Human genes 0.000 title abstract 2
- 108050007331 Cannabinoid receptor Proteins 0.000 title abstract 2
- 239000003446 ligand Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000030814 Eating disease Diseases 0.000 abstract 1
- 208000019454 Feeding and Eating disease Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 229930003827 cannabinoid Natural products 0.000 abstract 1
- 239000003557 cannabinoid Substances 0.000 abstract 1
- 239000003520 cannabinoid receptor affecting agent Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 235000014632 disordered eating Nutrition 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 230000004580 weight loss Effects 0.000 abstract 1
- 208000016261 weight loss Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to novel cannabinoid receptor modulators, in particular cannahinoid I (CB1) or cannabinoid 2 (CH2) receptor modulators, and uses thereof for treating diseases, conditions and/or disorders modulated by a cannabinoid receptor (such as pain, neurodegenerative disorders, eating disorders, weight loss or control, and obesity).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN659MU2005 | 2005-06-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA93390C2 true UA93390C2 (en) | 2011-02-10 |
Family
ID=39921101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200805952A UA93390C2 (en) | 2005-06-02 | 2006-06-01 | Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN101238107A (en) |
| ES (1) | ES2362369T3 (en) |
| UA (1) | UA93390C2 (en) |
| ZA (1) | ZA200711106B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA035989B1 (en) * | 2011-02-25 | 2020-09-09 | Арена Фармасьютикалз, Инк. | Crystalline forms and processes for the preparation of cannabinoid receptor modulators |
| CN110123813A (en) * | 2019-06-19 | 2019-08-16 | 深圳先进技术研究院 | Application and drug of the heterocyclic compound that plant of Solanaceae is extracted in the drug of preparation treatment multiple sclerosis |
-
2006
- 2006-06-01 CN CNA2006800285688A patent/CN101238107A/en active Pending
- 2006-06-01 UA UAA200805952A patent/UA93390C2/en unknown
- 2006-06-01 ES ES06755930T patent/ES2362369T3/en active Active
-
2007
- 2007-12-20 ZA ZA200711106A patent/ZA200711106B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200711106B (en) | 2008-11-26 |
| ES2362369T3 (en) | 2011-07-04 |
| CN101238107A (en) | 2008-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200716560A (en) | Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation | |
| TW200745126A (en) | Bicyclic heteroaryl derivatives as cannabinoid receptor modulators | |
| WO2007086080A3 (en) | NOVEL IMIDAZO[1,2-a]PYRIDINE CANNABINOID RECEPTOR LIGANDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| WO2008053341A3 (en) | Bridged bicyclic indazoles as cannabinoid receptor ligands | |
| WO2008035356A3 (en) | Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation | |
| TW200505837A (en) | Novel compounds | |
| TW200519075A (en) | Novel compounds | |
| MXPA05013711A (en) | 3-substituted 5,6-diaryl-pyrazine-2-carboxamide and -2-sulfonamide derivatives as cb1 modulators. | |
| WO2005080343A3 (en) | 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators | |
| TW200612892A (en) | Novel compounds | |
| TW200505442A (en) | Immunosuppressant compounds and compositions | |
| TW200505428A (en) | Immunosuppressant compounds and compositions | |
| EP1638551A4 (en) | Immunosuppressant compounds and compositions | |
| WO2005082089A3 (en) | Immunosuppressant compounds and compositions | |
| WO2004113330A8 (en) | Immunosuppressant compounds and compositions | |
| TW200630336A (en) | Novel compounds | |
| AU2003276028A1 (en) | Pyridine derivatives as cb2 receptor modulators | |
| TW200732296A (en) | Novel compounds | |
| ZA200807986B (en) | Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators | |
| TW200745003A (en) | Novel compounds | |
| TW200621690A (en) | Novel compounds | |
| MX2009003981A (en) | Calcium receptor modulating agents. | |
| WO2007120718A3 (en) | Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators | |
| WO2007120688A3 (en) | Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators | |
| WO2008010061A3 (en) | 3-azabicyclo [3.1.0] hexane vanilloid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation |